Alexander Hecht
🏛️ Revolving DoorFormer Government Position:
Chief Counsel, Senate Committee on Small Business Entrepreneurship
🤖
AI Overview
Alexander Hecht has appeared in 464 federal lobbying filings at Ml Strategies, LLC, representing 40 clients. As a former government official, they bring insider expertise to their lobbying work — part of Washington's "revolving door." Active across 23 policy areas.
464
Total Filings
1
Firms
40
Clients
23
Issue Areas
Issue Areas
Filing History
| Year | Filings | Clients |
|---|---|---|
| 2018 | 43 | 13 |
| 2019 | 46 | 13 |
| 2020 | 73 | 21 |
| 2021 | 48 | 11 |
| 2022 | 77 | 15 |
| 2023 | 78 | 16 |
| 2024 | 51 | 12 |
| 2025 | 48 | 13 |
Firms
Ml Strategies, LLC464 filings
Top Clients
Pricesmart, INC56 filings
Global Medical Response54 filings
Daikin U.S. Corporation33 filings
Immixgroup, INC.30 filings
Karl Storz Endoscopy - America, INC29 filings
Alliance of Tbi & Nhtd Waiver Providers29 filings
Wi-fi Alliance26 filings
Smartbiz Loans23 filings
Rebuilders Automotive Supply Co., INC.22 filings
Continuus Pharmaceuticals20 filings
Physical Sciences INC. (Psi)19 filings
Creare15 filings
Aircuity, INC.12 filings
Blue Cross Blue Shield of Michigan11 filings
Sorrento Therapeutics, INC.10 filings
Arrow Electronics, INC.10 filings
Breathablebaby6 filings
Immunomic Therapeutics6 filings
Related Analysis
Related Investigations
The Revolving Door Exposed
How former government officials become the most powerful lobbyists.
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
The Defense Lobby
Defense contractors spend millions lobbying for contracts worth billions.
Foreign Governments Are Lobbying Congress
1,000+ foreign entities from 50+ countries lobby the US government.
The 22,000% ROI
When lobbying spending yields outsized returns.
The 2025 Tariff Panic
As tariffs return, lobbying on trade surges.
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.